BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16166996)

  • 1. The role of chemotherapy in the treatment of esophageal cancer.
    Forastiere A
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):254-6. PubMed ID: 16166996
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problematic results of a randomized study of neoadjuvant radiochemotherapy of operable esophageal carcinoma].
    Fietkau R; Kundt G
    Strahlenther Onkol; 2001 Jul; 177(7):372-3. PubMed ID: 11505624
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question?
    Pereira B; Gourgou-Bourgade S; Azria D; Ychou M
    J Clin Oncol; 2008 Nov; 26(31):5133-4; author reply 5134. PubMed ID: 18838699
    [No Abstract]   [Full Text] [Related]  

  • 5. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
    Briasoulis E; Fatouros M; Roukos DH
    Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemoradiotherapy for esophageal cancer: real results and immediate perspectives].
    Tiuriaeva EI; Kanaev SV
    Vopr Onkol; 2012; 58(3):312-9. PubMed ID: 22888644
    [No Abstract]   [Full Text] [Related]  

  • 7. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical resection with and without chemotherapy in oesophageal cancer.
    Chander S
    Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387979
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in the treatment of esophageal cancer.
    Ilson DH
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):97-104. PubMed ID: 16163169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical resection with and without chemotherapy in oesophageal cancer.
    Bosset JF; Mercier M; Triboulet JP; Conroy T; Seitz JF
    Lancet; 2002 Oct; 360(9340):1173-4; author reply 1175. PubMed ID: 12387978
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
    Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perioperative multi-modality treatment strategies in esophageal cancer].
    Porschen R
    Z Gastroenterol; 1993 Nov; 31(11):680-5. PubMed ID: 8291282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy.
    Langer R; Becker K; Zlobec I; Gertler R; Sisic L; Büchler M; Lordick F; Slotta-Huspenina J; Weichert W; Höfler H; Feith M; Ott K
    Ann Surg Oncol; 2014 Mar; 21(3):915-21. PubMed ID: 24281419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meta-analysis of postoperative adjuvant chemotherapy for localized esophageal carcinoma].
    Huang WZ; Fu JH; Hu Y; Zhang X; Yang H
    Ai Zheng; 2006 Oct; 25(10):1303-6. PubMed ID: 17059782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
    Veuillez V; Rougier P; Seitz JF
    Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
    Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
    Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical resection with and without chemotherapy in oesophageal cancer.
    Maraveyas A; O'Boyle C; Cowen M
    Lancet; 2002 Oct; 360(9340):1174-5; author reply 1175. PubMed ID: 12387981
    [No Abstract]   [Full Text] [Related]  

  • 20. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
    Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
    J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.